A Randomized, Multi-Centric, Open Label, Comparative, Clinical Study to Evaluate the Efficacy And Safety of Trumove Spray In Patients with Musculo-Skeletal and Joint Pain

Tirupati Pharma, India0 个研究点目标入组 30 人开始时间: 待定最近更新: 2023年8月21日

试验速览

暂无简介。

•1. Patients of either sex aged above 18 years.
•2. Patients who are able to understand written and/or verbalinstructions and are ready to comply with all study requirements
•with a willingness to participate and give written informed consent voluntarily.
•3. Patients who had been diagnosed with acute and chronic localized musculoskeletal pain and joint pain (arthritis)

•1. Women of child bearing potential who are either unwilling or unable to use an acceptable method of birth control to avoid pregnancy during the study period.
•2. Subject with active skin lesions or other skin diseases.
•3. Subject with history of uncontrolled diabetes
•4. Subject with history of Periarthritis, rheumatoid arthritis
•5. Known allergy to compounds of investigational product.
•6. Participation in an investigational drug trial in the30 days prior to the screeningvisit.
•7. Patients of vulnerable group (children, lactating mother, elderly >80 years,handicapped, seriously ill, mentally challenged).
•8. History of drug or alcohol abuse during the last 6 months

发起方

Tirupati Pharma, India